共 22 条
[5]
Addition of epirubicin as a third drug to carboplatin-paclitaxel in first-line treatment of advanced ovarian cancer: A prospectively randomized gynecologic cancer intergroup trial by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group and the Groupe d'Investigateurs Nationaux pour l'Etude des Cancers Ovariens
[J].
JOURNAL OF CLINICAL ONCOLOGY,
2006, 24 (07)
:1127-1135
[7]
A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer
[J].
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE,
2003, 95 (17)
:1320-1330